RSCM
ALBO

Rock Springs Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Rock Springs Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-133,333
Closed -$1.76M – 124
2015
Q3 		$1.76M Hold
133,333
– – 0.14% 115
2015
Q2 		$4.12M Buy
+133,333
New +$4.48M 0.3% 100

Other funds holding ALBO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Rock Springs Capital Management's ALBO Position: Q4 2015 in Review

Rock Springs Capital Management sold out of Albireo Pharma Inc (ALBO) in Q4 2015, closing a stake of 133,333 shares — an estimated $1.76M sold.

Rock Springs Capital Management first reported a position in ALBO in Q2 2015 and held it in 2 quarters. The position peaked at $4.12M in Q2 2015. 33 funds tracked by Wall St. Rank hold ALBO as of Q4 2015.

  • Rock Springs Capital Management reported no remaining Albireo Pharma Inc position as of Q4 2015 after selling out during the quarter.
  • Rock Springs Capital Management sold 133,333 Albireo Pharma Inc shares in Q4 2015, an estimated $1.76M.
  • Rock Springs Capital Management first reported a position in Albireo Pharma Inc in Q2 2015 and held it in 2 quarters.
  • Rock Springs Capital Management's Albireo Pharma Inc position peaked at $4.12M in Q2 2015.
  • 33 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2015.

Based on Rock Springs Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.